PepsiCo, Inc. (NASDAQ:PEP) is making bold operational shifts across its global portfolio as it navigates shifting demand ...

Guidance was raised from $7.60–$7.90 EPS to $7.75–$8, now inclusive of tariffs. Margin expansion guidance increased from "upside to the midpoint" to a specified "150 to 200 basis points" for the year.

QuantumScape's stock has surged on Cobra separator news, but true commercial production and revenue remain years away. See ...

A trial testing a nerve-sparing (NeuroSAFE) technique in radical prostatectomy may improve patient-reported outcomes.

Breastfeeding did not appear to be associated with a higher risk of developing locoregional recurrences or contralateral breast cancers,” researchers wrote.

Background Restarting direct oral anticoagulants (DOACs) after a serious bleeding event in patients with atrial fibrillation ...

Q3 2025 Earnings Call Transcript July 14, 2025 Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.45, ...

The Motley Fool. DATE Tuesday, July 15, 2025 at 8:00 a.m. ET Read More: Earn up to $845 cash back this year just by changing ...

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

15-year-old Nolan Grove testified in his homicide trial, claiming the shooting of 12-year-old Kain Heiland was accidental. Surveillance footage tracked the boys' movements leading up to the ...

A phase 3 trial of Cogent Biosciences’ bezuclastinib has hit its primary endpoint, teeing the biotech up to seek FDA approval ...